期刊文献+

PTPN6重组蛋白的真核表达纯化及功能鉴定

Recombinant protein PTPN6 eukaryotic expression,purification and functional identification
原文传递
导出
摘要 [目的]构建真核表达载体pENTER-PTPN6,在HEK293T细胞中表达并纯化,并初步探讨PTPN6对肺癌细胞系A549细胞增殖能力的影响。[方法]构建真核表达载体pENTER-PTPN6,利用jetPRIME分别转染HEK293T和A549细胞,用Western Blot检测PTPN6在细胞中的表达情况,并通过磁珠纯化PTPN6蛋白,最后利用CCK-8法检测PTPN6对A549的增殖影响并绘制细胞生长曲线。[结果]Western Blot结果显示转染细胞内有PTPN6的高表达,磁珠纯化得到高纯度的目标蛋白,而且转染后的肺癌细胞A549增殖能力较对照组显著下降。[结论]成功构建了真核表达质粒pENTER-PTPN6并在真核表达系统中表达和纯化,重组PTPN6具有抑制A549细胞的增殖的作用,为进一步探讨PTPN6基因的功能及寻找治疗肺癌新方向奠定了基础。 [Objective]To construct eukaryotic expression vector pENTER-PTPN6 and observe the effect of PTPN6 protein on the proliferation of lung cancer cell line A549. [Methods]The eukaryotic expression vector pENTER-PTPN6 was constructed and transfected into cell line HEK293 T and A549 via jetPRIME expression of PTPN6 in cells was detected with the help of Western Blotting and purified with magnetic beads,finally the cell growth curve was gained through the Cell Counting Kit-8 method. [Results]Western Blotting confirmed that PTPN6 was highly expressed in transfected cells and purified by magnetic beads. What's more,PTPN6 significantly depressed the proliferation of A549 cells compared with the control group.[Conclusion]The eukaryotic expression vector pENTER-PTPN6 was successfully constructed and expressed effectively in eukaryotic expression system. The cell growth curve showed that PTPN6 significantly inhibited the proliferation of A549 cells,which laid the basis for further research of biological function of PTPN6 and new treatment of lung cancer.
出处 《生物技术》 北大核心 2017年第5期428-433,共6页 Biotechnology
基金 国家自然科学基金项目("羊口疮病毒ORFV118蛋白调控宿主细胞凋亡的分子机制研究" No.31672536)
关键词 PTPN6 A549 真核表达 增殖 PTPN6, A549, eukaryotic expression, proliferation
  • 相关文献

参考文献1

二级参考文献39

  • 1Beyreuther H. Multipicate von carcinomen bei einem fall von sog.Schenecberger Lungenkrebs mit tuberkulose. Virchows Arc, 1924,250(1-2):230-243.
  • 2Antakli T, Schaefer RF, Rutherford JE, et al. Second primary lung cancer.Ann Thorac Surg, 1995, 59(4): 863-866.
  • 3Wang X, Wang M, MacLennan GT, et al. Evidence for common clonalorigin of multifocal lung cancers. J Natl Cancer Inst, 2009, 101(8):560-570.
  • 4Gazdar AF, Minna JD. Multifocal lung cancers--clonality vs fieldcancerization and does it matter? J Natl Cancer Inst, 2009, 101(8):541-543.
  • 5Ishigaki T, Yoshimasu T, Oura S, et al. Surgical treatment formetachronous second primary lung cancer after radical resection ofprimary lung cancer. Ann Thorac Cardiovasc Surg, 2013,19(5): 341-344.
  • 6Ishikawa Y, Nakayama H, Ito H, et al. Surgical treatment for synchronousprimary lung adenocarcinomas. Ann Thorac Surg, 2014, 98(6):1983-1988.
  • 7Port JL, Korst RF, Lee PF, et al. Surgical resection for multifocal (T4)non-small cell lung cancer: is the T4 designation valid? Ann Thorac Surg,2007,83(2):397-400.
  • 8Battafarano RJ, Meyers BF, Guthrie TF, et al. Surgical resection ofmultifocal non-small cell lung cancer is associated with prolongedsurvival. Ann Thorac Surg, 2002, 74(4): 988-993.
  • 9Pillai RN, Lee SJ, Karp DD, et al. Second primary lung cancers: Analysisof E5597 selenium chemoprevention study. J Clin Oncol, 2014, 32(15):7518-7526.
  • 10Chang YL, Wu CT, Lin SC, et al. Clonality and prognostic implications ofp53 and epidermal growth factor receptor somatic aberrations in multipleprimary lung cancers. Clin Cancer Res, 2007,13(1): 52-58.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部